Coccinia grandis
Coccinia grandis
Coccinia grandis, commonly known as African squash or bitter melon, originates from traditional medicine practices in Africa. While its use is not extensively documented, it has shown promise in various studies for its potential anti-inflammatory, antimicrobial, and antioxidant properties. Research indicates that Lupeol, a compound found in Coccinia grandis leaves, demonstrates antimicrobial activity comparable to standard antibiotics against carbapenem-resistant Klebsiella pneumoniae. Additionally, leaf extracts have been observed to improve kidney function, reduce oxidative stress, and decrease pro-inflammatory cytokines in rats fed a high-lipid diet. However, more human trials are necessary to confirm these findings comprehensively. No major safety issues or recorded drug interactions have been identified thus far.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study finds that Coccinia grandis, along with other plants, shows potential anti-inflammatory, antimicrobial, and antioxidant activities in managing atopic dermatitis symptoms, but more human trials are needed.
- The study found that Lupeol, from Coccinia grandis leaves, showed antimicrobial activity against carbapenem-resistant Klebsiella pneumoniae with a zone of inhibition comparable to standard antibiotics.
- Coccinia grandis leaf extract improved kidney function, reduced oxidative stress, and decreased pro-inflammatory cytokines in rats fed a high-lipid diet.
- Comprehensive research suggests that Coccinia grandis exhibits various biological activities but specific phytoconstituents and mechanisms remain to be fully identified.
Frequently asked questions
What is Coccinia grandis?
Coccinia grandis (Coccinia grandis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Coccinia grandis?
4 sourced findings are recorded for Coccinia grandis; the strongest carries evidence grade D. For example: The study finds that Coccinia grandis, along with other plants, shows potential anti-inflammatory, antimicrobial, and antioxidant activities in managing atopic dermatitis symptoms, but more human trials are needed.
How strong is the evidence for Coccinia grandis?
The strongest finding for Coccinia grandis carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Coccinia grandis safe? What are the side effects?
No major safety issues are recorded for Coccinia grandis in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Coccinia grandis interact with medications?
No drug interactions are recorded for Coccinia grandis in our sources. This does not rule them out — check with a pharmacist.
Is Coccinia grandis a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 The therapeutic role of Coccinia grandis in flavor-enhancing high-lipid diet-induced chronic kidney disease: a dual role of NF-kB and TGF-β/smad in renal fibrosis. literature abstract metadata
- T2 Ethnomedicinal Uses, Phytochemistry, Pharmacological Activity, Therapeutic Potentials, and Functional Foods of Coccinia grandis (L.) Voigt: An Updated Review. literature abstract metadata
- T2 Biological assessment of Coccinia grandis leaf and Lupeol against β-lactam resistant Klebsiella pneumoniae through integrated in-silico and in-vitro studies. literature abstract metadata
- T2 Phytotherapeutic Potential of Medicinal Plants for Atopic Dermatitis: Centella asiatica, Clinacanthus nutans, Senna alata, and Coccinia grandis. literature abstract metadata